Transfusion of 7-day-old amotosalen photochemically treated buffy-coat platelets to patients with thrombocytopenia: A pilot study

Transfusion

Volumn 46, Issue 3, 2006, Pages 424-433

  Simonsen, Anne C ^b   Johansson, Pär I ^b   Conlan, Maureen G ^b   Jacquet, Michele ^b   Lin, Jin Sying ^b   Junge, Klaus ^b   Lin, Lily ^a   Sørensen, Henning ^b   Borregaard, Niels ^b   Flament, Jocelyne ^b  

^a CERUS CORPORATION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOTOSALEN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HEMOSTASIS; HUMAN; MALE; PHOTOCHEMISTRY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BLOOD PRESERVATION; FEMALE; HEMOSTASIS; HUMANS; MALE; MICROBIAL VIABILITY; PILOT PROJECTS; PLATELET TRANSFUSION; PSORALENS; PUVA THERAPY; THROMBOCYTOPENIA; TIME FACTORS;

EID: 33644687551     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00739.x     Document Type: Article

References (28)

1. Braine HG Kickler TS Charache P et al. Bacterial sepsis secondary to platelet transfusion: an adverse effect of extended storage at room temperature Transfusion 1986 26 391 3
2. Heal JM Singal S Sardisco E Mayer T Bacterial proliferation in platelet concentrates Transfusion 1986 26 388 90
3. Esber E Reduction of the maximum platelet storage period to 5 days in an approved container FDA memorandum. Rockville (MD) U.S. Food and Drug Administration 1986
4. Blajchman MA Goldman M Baeza F Improving the bacteriological safety of platelet transfusions Transfus Med Rev 2004 18 11 24
5. te Boekhorst PE Beckers EA Vos MC Vermeij H van Rhenen DJ Clinical significance of bacteriologic screening in platelet conentrates Transfusion 2005 45 514 9
6. Chiu EK Yuen KY Lie AK et al. A prospective study of symptomatic bacteremia following platelet transfusion and of its management Transfusion 1994 34 950 4
7. Larsen CP Ezligini F Hermansen NO Kjeldsen-Kragh J Six years' experience of using the BacT/ALERT system to screen all platelet concentrates, and additional testing of outdated platelet concentrates to estimate the frequency of false-negative results Vox Sang 2005 88 93 7
8. Dumont LJ AuBuchon JP Whitley P et al. Seven-day storage of single-donor platelets: recovery and survival in an autologous transfusion study Transfusion 2002 42 847 54
9. Cardigan R Williamson LM The quality of platelets after storage for 7 days Transfus Med 2003 13 173 87
10. Dijkstra-Tiekstra MJ Pietersz RN Hendriks EC et al. In vivo PLT increments after transfusions of WBC-reduced PLT concentrates stored for up to 7 days Transfusion 2004 44 330 6
11. Wollowitz S Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma Semin Hematol 2001 38 4 Suppl 11 4 11
12. Lin L Cook DN Wiesehahn GP et al. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light Transfusion 1997 37 423 35
13. Knutson F Alfonso R Dupuis K et al. Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function Vox Sang 2000 78 209 16
14. Lin L Dikeman R Molini B et al. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria Transfusion 2004 44 1496 504
15. Lin L Hanson CV Alter HJ et al. Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light Transfusion 2005 45 580 90
16. Van Voorhis WC Barrett LK Eastman RT et al. Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen (amotosalen HCl) and long-wavelength UV Antimicrob Agents Chemother 2003 47 475 9
17. Grass JA Wafa T Reames A et al. Prevention of transfusion-associated graft-versus-host disease by photochemical treatment Blood 1999 93 3140 7
18. Grass JA Hei DJ Metchette K et al. Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA Blood 1998 91 2180 8
19. Corash L Lin L Novel processes for inactivation of leukocytes to prevent transfusion-associated graft-versus-host disease Bone Marrow Transplant 2004 33 1 7
20. Schlenke P Protection against transfusion-associated graft-versus-host disease in blood transfusion: is gamma-irradiation the only answer? Transfus Med Hemother 2004 31 24 32
21. McCullough J Vesole DH Benjamin RJ et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial Blood 2004 104 1534 41
22. van Rhenen D Gulliksson H Cazenave JP et al. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial Blood 2003 101 2426 33
23. Janetzko K Cazenave JP Kluter H et al. Therapeutic efficacy of photochemically treated aphaeresis platelets processed with an optimized set Transfusion 2005 45 1443 52
24. Picker SM Speer R Gathof BS Functional characteristics of buffy-coat PLTs photochemically treated with amotosalen-HCl for pathogen inactivation Transfusion 2004 44 320 9
25. Ishida A Handa M Wakui M et al. Clinical factors influencing posttransfusion platelet increment in patients undergoing hematopoietic progenitor cell transplantation - a prospective analysis Transfusion 1998 38 839 47
26. Snyder E Raife T Lin L et al. Recovery and life span of 111indium-radiolabeled platelets treated with pathogen inactivation with amotosalen HCl (S-59) and ultraviolet A light Transfusion 2004 44 1732 40
27. Davis KB Slichter SJ Corash L Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response. problems and a solution Transfusion 1999 39 586 92
28. Slichter SJ Davis K Enright H et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients Blood 2005 105 4106 14